Trinity Legacy Partners, LLC Abb Vie Inc. Put Options Transaction History

Trinity Legacy Partners, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $244,720 - $277,794	-2,300 Reduced 88.46%	300 $0
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $94,689 - $105,489	900 Added 52.94%	2,600 $3,000
Q1 2021 Apr 21, 2021	BUY	$102.3 - $112.62 $92,070 - $101,358	900 Added 112.5%	1,700 $6,000
Q4 2020 Jan 20, 2021	BUY	$80.49 - $108.67 $64,391 - $86,936	800 New	800 $5,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Trinity Legacy Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Trinity Legacy Partners, LLC with notifications on news.